Medical Affairs & Communications Launch Readiness Summit

Optimize the collaboration between cross-functional leadership and engage with key stakeholders for the preparation and execution of a successful launch


Boston, MA, United States

In order to execute a successful product launch, medical affairs require an immense amount of operational and effective execution. Medical Affairs facilitate planning, and coordinate activities by time frame from pre-launch to post-launch to meet product launch expectations.

With increasingly crowded therapeutics areas in the pharmaceutical industry and a more restricted promotional environment, medical affairs professionals must increase its role in product launch to prepare the marketplace to drive increased awareness and the probability of success.

At our Medical Affairs & Communications Launch Readiness Summit medical affairs professionals will be able to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase the knowledge and communications with thought leaders.

Top Five Reasons to Attend:

  1. Illustrate how medical affairs is involved in the launch process in biotech and pharmaceutical companies
  2. Understand challenges in managing successful medical affairs launch support
  3. Highlight strategies for effective thought leader segmentation and relationship management
  4. Explore and define strategies for allocating medical affairs launch budget effectively
  5. Define industry best practices for new product pre-commercialization

Who Should Attend:

This conference is designed for representatives from pharmaceutical, biotechnology, and medical device organizations with responsibilities in the following areas:
  • Clinical/Medical/Global Affairs
  • Medical Directors
  • Medical Science Liaisons/MSLs
  • Medical Strategy/Communications
  • KOL Thought Leader Relations
  • Product Launch
  • Brand Management
  • Commercial Operations
  • Market Access
  • Marketing
  • Distribution
  • Product Management
  • Strategy & Operation
This conference is also designed for:
  • KOL/Thought Leader Mapping Organizations
  • Data Management Solution Providers
  • Communications Agencies
  • Software Communications
  • Marketing Consultants
  • Medical Affairs Service Organizations

Speakers

  • Kavita Aggarwal, Vice President, Medical Affairs, DOVA PHARMACEUTICALS
  • Richa Attre, Associate Director, Publications Management, Medical Affairs, REGENERON PHARMACEUTICALS
  • Meghan Bagshaw, Director, Global Medical Affairs, SAGE THERAPEUTICS
  • Howard Berkowitz, Respiratory and Immunology Medical Science Liaison US Field-Based Medical Affairs, SANOFI GENZYME
  • Rebecca Burnett, Executive Director and Head of Strategic Services, FRAMEWORK SOLUTIONS
  • Jason Crompton, Pharm.D.,Associate Director, Global Scientific Communications Head, Neurodegeneration and Pipeline Scientific Communications, BIOGEN
  • Howard Dorfman, Adjunct Professor, SETON HALL UNIVERSITY SCHOOL OF LAW, Founder, H.L. DORFMAN CONSULTING
  • Peter L. Goldberg, Ph.D., Field Medical Strategist - Rheumatology, East U.S. Immunology Patient Value Unit, U.S. Medical Affairs, UCB
  • Lubna Jamal, Real-World Evidence Consultant, PROGENICS PHARMACEUTICALS
  • Daniel Jones, Medical Director and U.S. Lead - M.S. Franchise, Interferons, Opicinumab, EMD SERONO
  • Peter Lee, Vice President, Chief Compliance Officer, HERON THERAPEUTICS
  • Robin LeWinter, Senior Director, Medical Affairs Communications, ORCHARD THERAPEUTICS
  • Barry Lubarsky, Ph.D., Senior Medical Director, Medical Affairs, ALKERMES
  • Alison Martens, RN, BSN, CCRP, Medical Science Liaison, Northeast Region and Team Lead, MEDA PHARMACEUTICALS
  • Scott McConnell, Scientific Affairs Consultant, KALEIDO BIOSCIENCES
  • Ray Pourfarzib, Ph.D., Executive Director and TA Medical Lead Metabolics, ALEXION PHARMACEUTICALS
  • Kanchan Relwani, M.D., Vice President, Medical Strategy, Medical Affairs, ALKERMES
  • Daniel Snyder, Senior Director Medical Affairs, REVANCE THERAPEUTICS
  • Tyson Tu, Director and Head, Medical Communications, ALKERMES
  • Irene von Hennigs, Pharm.D., Executive Director and TA Medical Lead Complement, Hematology and Nephrology, ALEXION PHARMACEUTICALS
  • Courtney Zeni, Associate Medical Director, Product Development, NOVEN PHARMACEUTICALS
  • Jenny Zhang, Associate Director, Portfolio and Strategy Launch Lead, Global Medical Affairs - Oncology, EMD SERONO
  • Steven Zhang, Vice President, Medical Affairs, KALA PHARMACEUTICALS

Please fill in your name and email to receive the Summit Agenda of this event.

Venue

Revere Hotel Boston Common
200 Stuart St, 02116
Boston, MA, USA

Shaped by the local culture and rebellious, independent spirit fueling Boston since its founding, Revere Hotel Boston Common is the downtown hotel for the adventurous and authentic. Find our hotel steps from Boston's Theater District, Newbury Street, and Copley Square. Stay in boutique rooms with views overlooking the city skyline and our Back Bay neighborhood. Dine like a local on authentic New England cuisine and raise a glass at Rooftop at Revere, the most exclusive rooftop bar and lounge in Boston.

To make reservations, please call 1-855-673-8373 and request the group rate for ExL's December Meetings. You may also make reservations online using the CLICK HERE

The group rate is available until November 11, 2019. Please book your room early, as rooms available at this rate are limited.